Dr Vikas Dembla, MD | |
101 E Wood St, Spartanburg, SC 29303-3040 | |
(864) 560-7050 | |
(864) 560-0800 |
Full Name | Dr Vikas Dembla |
---|---|
Gender | Male |
Speciality | Hematology/oncology |
Experience | 23 Years |
Location | 101 E Wood St, Spartanburg, South Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013128792 | NPI | - | NPPES |
403290 | Medicaid | SC | |
SC96873365 | Other | SC | MEDICARE PIN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 632-L (Mississippi) | Secondary |
207RH0003X | Internal Medicine - Hematology & Oncology | 40329 (South Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Spartanburg Medical Center | Spartanburg, SC | Hospital |
Pelham Medical Center | Greer, SC | Hospital |
Cherokee Medical Center | Gaffney, SC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Spartanburg Medical Center | 3072425297 | 843 |
News Archive
Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. today announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00 per share in cash, or a total enterprise value of approximately $14.5 billion.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, Inc., has been granted orphan-drug designation by the U.S. Food and Drug Administration for perifosine, Aeterna Zentaris' novel, potentially first-in-class, oral Akt inhibitor, for the treatment of neuroblastoma.
Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.
Suicide in children under age 20 has been increasing in the U.S., with rates almost doubling over the last decade.
› Verified 4 days ago
Entity Name | Spartanburg Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043309917 PECOS PAC ID: 3072425297 Enrollment ID: O20031105000129 |
News Archive
Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. today announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00 per share in cash, or a total enterprise value of approximately $14.5 billion.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, Inc., has been granted orphan-drug designation by the U.S. Food and Drug Administration for perifosine, Aeterna Zentaris' novel, potentially first-in-class, oral Akt inhibitor, for the treatment of neuroblastoma.
Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.
Suicide in children under age 20 has been increasing in the U.S., with rates almost doubling over the last decade.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Vikas Dembla, MD Po Box 743070, Atlanta, GA 30374-3070 Ph: (864) 560-4304 | Dr Vikas Dembla, MD 101 E Wood St, Spartanburg, SC 29303-3040 Ph: (864) 560-7050 |
News Archive
Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. today announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00 per share in cash, or a total enterprise value of approximately $14.5 billion.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that its partner, Keryx Biopharmaceuticals, Inc., has been granted orphan-drug designation by the U.S. Food and Drug Administration for perifosine, Aeterna Zentaris' novel, potentially first-in-class, oral Akt inhibitor, for the treatment of neuroblastoma.
Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.
Suicide in children under age 20 has been increasing in the U.S., with rates almost doubling over the last decade.
› Verified 4 days ago
Dr. Tondre Buck, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 E Wood St, Spartanburg, SC 29303 Phone: 864-560-7050 Fax: 864-560-0800 | |
Adam Evec, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 E Wood St Ste 500, Spartanburg, SC 29303 Phone: 864-560-4304 Fax: 864-560-4023 | |
Larry E Kibler, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1083 Boiling Springs Rd, Spartanburg, SC 29303 Phone: 864-583-8647 Fax: 864-542-2227 | |
Dr. Andrew Omoit Ekatan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 E Wood St, Suite 401, Spartanburg, SC 29303 Phone: 864-560-6654 Fax: 864-560-7353 | |
Stetson Reed Bickley, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 101 E Wood St, Spartanburg, SC 29303 Phone: 864-560-6522 Fax: 888-972-8644 | |
Dr. Ryan Scott Rhodes, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 101 E Wood St, Spartanburg, SC 29303 Phone: 843-330-8923 |